| Year |
Citation |
Score |
| 2024 |
Serrano D, Cella D, Husereau D, King-Kallimanis B, Mendoza T, Salmonson T, Stone A, Zaleta A, Dhanda D, Moshyk A, Liu F, Shields AL, Taylor F, Spite S, Shaw JW, et al. Administering selected subscales of patient-reported outcome questionnaires to reduce patient burden and increase relevance: a position statement on a modular approach. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 38265747 DOI: 10.1007/s11136-023-03587-8 |
0.302 |
|
| 2019 |
Mesa RA, Su Y, Woolfson A, Prchal JT, Turnbull K, Jabbour E, Scherber R, Shields AL, Krohe M, Ojo F, Pompilus F, Cappelleri JC, Harrison C. Development of a symptom assessment in patients with myelofibrosis: qualitative study findings. Health and Quality of Life Outcomes. 17: 61. PMID 30975150 DOI: 10.1186/S12955-019-1121-1 |
0.385 |
|
| 2019 |
Hirano I, Dellon ES, Murray J, Peterson KA, Banderas B, Woolley JM, Ollis S, Foley C, Love E, Shields A, Shaw C, Rasmussen HS. 1247 Development of a Patient Reported Outcome (PRO) Questionnaire to Assess the Symptoms of Eosinophilic Gastritis and Gastroenteritis (EG/EGE-SQ©) The American Journal of Gastroenterology. 114. DOI: 10.14309/01.Ajg.0000594516.37251.84 |
0.386 |
|
| 2019 |
Banderas B, Lizzul P, Ahluwalia G, Liu C, Kinchev P, Stroehmann D, Li S, Galipeau N, Mossman B, McDonald J, Shields A. Psy51 Psychometric Performance Of Plaque Psoriasis Patient Reported Outcome Numeric Rating Scales In A Phase 2B Clinical Trial Value in Health. 22. DOI: 10.1016/J.Jval.2019.09.2678 |
0.314 |
|
| 2019 |
Taylor F, Shields A, Li S, Yip C, Padilla B, Green T, Radia D, Deininger M, Gotlib JR, Bose P, Drummond MW, Hexner E, Robinson W, Quiery A, Winton EF, et al. Pro143 Psychometric Evaluation Of The Advanced Systemic Mastocytosis Symptom Assessment Form (Advsm-Saf) In Patients With Advanced Systemic Mastocytosis Value in Health. 22. DOI: 10.1016/J.Jval.2019.09.2472 |
0.327 |
|
| 2019 |
Shields A, Taylor F, Lamoureux R, Padilla B, Severson K, Green T, Mar B. Pro142 Psychometric Performance Of The Indolent Systemic Mastocytosis Symptom Assessment Form (Ism-Saf) Value in Health. 22. DOI: 10.1016/J.Jval.2019.09.2471 |
0.32 |
|
| 2018 |
Turner-Bowker DM, Lamoureux RE, Stokes J, Litcher-Kelly L, Galipeau N, Yaworsky A, Solomon J, Shields AL. Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 839-842. PMID 30005756 DOI: 10.1016/J.Jval.2017.11.014 |
0.359 |
|
| 2018 |
Yu-Isenberg K, Gray GD, Foley C, Stokes JT, Shields A, Dickie G, Lamoureux R, Jackson CV, Padilla B, Polonsky W. Exploring the Type 2 Diabetes Mellitus Experience from the Patient Perspective Diabetes. 67. DOI: 10.2337/Db18-725-P |
0.325 |
|
| 2018 |
Dickie G, Mazar I, Espensen A, Lamoureux R, Severson K, Padilla B, Shields A. Pmu118 - Cognitive Debriefing Interview Studies To Inform Patient-Reported Outcome Questionnaire Development: A Literature Review And Suggested Reporting Guidelines Value in Health. 21. DOI: 10.1016/J.Jval.2018.09.1954 |
0.316 |
|
| 2017 |
Taylor F, Higgins S, Carson RT, Eremenco S, Foley C, Lacy BE, Parkman HP, Reasner DS, Shields AL, Tack J, Talley NJ. Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD). The American Journal of Gastroenterology. PMID 28925989 DOI: 10.1038/Ajg.2017.265 |
0.342 |
|
| 2017 |
Banderas B, Skup M, Shields AL, Stokes J, Foley C, Ganguli A. Psychometric evaluation of the Rheumatoid Arthritis Symptom Questionnaire (RASQ) in an observational study. Current Medical Research and Opinion. 1-31. PMID 28885061 DOI: 10.1080/03007995.2017.1378173 |
0.342 |
|
| 2017 |
Kimball AB, Sundaram M, Banderas B, Foley C, Shields AL. Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa. The Journal of Dermatological Treatment. 1-40. PMID 28608738 DOI: 10.1080/09546634.2017.1341614 |
0.39 |
|
| 2017 |
Banderas B, Skup M, Shields AL, Mazar I, Ganguli A. Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis. Current Medical Research and Opinion. 1-27. PMID 28574727 DOI: 10.1080/03007995.2017.1338562 |
0.334 |
|
| 2017 |
Armstrong AW, Banderas B, Foley C, Stokes J, Sundaram M, Shields AL. Development and Psychometric Evaluation of the Self-Assessment of Psoriasis Symptoms (SAPS) - Clinical Trial and the SAPS - Real World Patient-Reported Outcomes. The Journal of Dermatological Treatment. 1-41. PMID 28147886 DOI: 10.1080/09546634.2017.1290206 |
0.342 |
|
| 2017 |
Mazar I, Stokes J, Foley C, Galipeau N, Shields A. Qualitative Research Methods For Collecting, Analyzing, And Presenting Patient-Reported Data On Noticeable And Important Change In Disease-Related Signs And Symptoms Value in Health. 20. DOI: 10.1016/J.Jval.2017.08.2172 |
0.306 |
|
| 2016 |
Turner-Bowker DM, Hao Y, Foley C, Galipeau N, Mazar I, Krohe M, Globe D, Shields AL. The Use of Patient-Reported Outcomes in Advanced Breast Cancer Clinical Trials: A Review of the Published Literature. Current Medical Research and Opinion. 1-37. PMID 27331272 DOI: 10.1080/03007995.2016.1205005 |
0.332 |
|
| 2016 |
Taylor F, Reasner DS, Carson RT, Deal LS, Foley C, Iovin R, Lundy JJ, Pompilus F, Shields AL, Silberg DG. Development of a Symptom-Based Patient-Reported Outcome Instrument for Functional Dyspepsia: A Preliminary Conceptual Model and an Evaluation of the Adequacy of Existing Instruments. The Patient. PMID 27020447 DOI: 10.1007/S40271-016-0164-1 |
0.389 |
|
| 2016 |
Su Y, Woolfson A, Prchal JT, Turnbull KW, Harrison CN, Jabbour E, Scherber RM, Shields A, Krohe M, Ojo F, Pompilus F, Mesa RA. Symptom assessment in patients with JAK inhibitor naïve and JAK inhibitor failed myelofibrosis. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E18559 |
0.351 |
|
| 2016 |
Mazar, Evans E, Taylor F, Patki A, Ojo O, Lamoureux R, Horny H, Reiter A, Gotlib J, Shields A. Development and Content Validity of the Advanced Systemic Mastocytosis Symptom Assessment Form (ADVSM-SAF) Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.224 |
0.346 |
|
| 2016 |
Spalding J, Hudgens S, Litcher-Kelly L, Shields A, Kitt T, Ojo O, Kristy R, Lee E, Mathias A, Morrissey L, Houle C. Psychometric Analyses of Clinical Outcome Assessment (Coa) Questionnaires Designed to Evaluate Satisfaction with Pharmacological Stress Agents (Psas) Used in Echocardiography Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.070 |
0.317 |
|
| 2016 |
Jacobson T, Edelman S, Davidson M, Galipeau N, Shields A, Mallya U, Koren A. Development and Content Validation of a Patient-Reported Outcome Measure to Evaluate Statin Intolerance in the Real World Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.173 |
0.353 |
|
| 2015 |
Shields A, Coon C, Hao Y, Krohe M, Yaworsky A, Mazar I, Foley C, Globe D. Patient-reported outcomes for US oncology labeling: review and discussion of score interpretation and analysis methods. Expert Review of Pharmacoeconomics & Outcomes Research. 1-9. PMID 26594897 DOI: 10.1586/14737167.2015.1115348 |
0.415 |
|
| 2015 |
Kimball A, Sundaram M, Mathias A, Foley C, Shields A. Measuring Disease specific impact and symptoms among patients with Hidradenitis Suppurativa Value in Health. 18. DOI: 10.1016/J.Jval.2015.03.1061 |
0.319 |
|
| 2014 |
Pleil A, Mathias A, Galipeau N, Shields A, Jensen J. The Reliability Of The Patient-Reported Scar Evaluation Questionnaire (Pr-Seq) In A Cohort Of Adults With Linear Scars Value in Health. 17. DOI: 10.1016/J.Jval.2014.03.1677 |
0.349 |
|
| 2013 |
Stokes J, Evans CJ, Pompilus F, Shields AL, Summers KH. Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials. The Patient. 6: 291-305. PMID 24062234 DOI: 10.1007/S40271-013-0026-Z |
0.341 |
|
| 2013 |
Strober BE, Nyirady J, Mallya UG, Guettner A, Papavassilis C, Gottlieb AB, Elewski BE, Turner-Bowker DM, Shields AL, Gwaltney CJ, Lebwohl M. Item-level psychometric properties for a new patient-reported psoriasis symptom diary. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 16: 1014-22. PMID 24041351 DOI: 10.1016/J.Jval.2013.07.002 |
0.381 |
|
| 2013 |
Connery H, Greenfield S, Livchits V, McGrady L, Patrick N, Lastimoso CS, Heney JH, Nelson AK, Shields A, Stepanova YP, Petrova LY, Anastasov OV, Novoseltseva OI, Shin SS. Training and fidelity monitoring of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia: the IMPACT Effectiveness Trial. Substance Use & Misuse. 48: 784-92. PMID 23750742 DOI: 10.3109/10826084.2013.793715 |
0.326 |
|
| 2013 |
Mesa RA, Shields A, Hare T, Erickson-Viitanen S, Sun W, Sarlis NJ, Sandor V, Levy RS, Verstovsek S. Progressive burden of myelofibrosis in untreated patients: assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study. Leukemia Research. 37: 911-6. PMID 23684482 DOI: 10.1016/J.Leukres.2013.04.017 |
0.416 |
|
| 2013 |
Mesa RA, Gotlib J, Gupta V, Catalano JV, Deininger MW, Shields AL, Miller CB, Silver RT, Talpaz M, Winton EF, Harvey JH, Hare T, Erickson-Viitanen S, Sun W, Sandor V, et al. Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1285-92. PMID 23423753 DOI: 10.1200/Jco.2012.44.4489 |
0.401 |
|
| 2013 |
Trask PC, Taylor F, Shields A, Gallagher M, Mehta J, Foley C, Olude F, Lamoureux R, Iovin R, Hsu K. Qualitative Assessment Of Symptoms and Functional Impact In Relapsed/Refractory Multiple Myeloma Patients and Comparison To The EORTC QLQ-C30 and My-20, FACT-MM, and MDASI-MM Blood. 122: 2989-2989. DOI: 10.1182/Blood.V122.21.2989.2989 |
0.352 |
|
| 2013 |
Pleil A, Jensen J, Galipeau N, Shields A. Is a picture worth a thousand words? the development of a clinician and patient reported photonumeric guide to assess scar severity Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.183 |
0.332 |
|
| 2012 |
Pleil A, Jensen J, Galipeau N, Olude O, Klemm M, Shields A. PSS27 Do Scars Impact Beyond Just Appearance? A Report of the Content Elicitation (CE) Phase in the Development of the Patient Reported Scar Evaluation Quesionnaire (PR-SEQ) Value in Health. 15. DOI: 10.1016/J.Jval.2012.08.2074 |
0.303 |
|
| 2012 |
Mesa R, Shields A, Hare T, Erickson-Viitanen S, Sun W, Verstovsek S. PCN109 Progressive Worsening of Patient-Reported Outcomes in Untreated Patients With Myelofibrosis Value in Health. 15. DOI: 10.1016/J.Jval.2012.03.1226 |
0.309 |
|
| 2011 |
Mesa RA, Gotlib J, Gupta V, DiPersio JF, Catalano J, Deininger MW, Shields A, Miller CB, Silver RT, Talpaz M, Winton EF, Harvey JH, Hare T, Erickson-Viitanen S, Sun W, et al. Associations Between Improvements in Myelofibrosis (MF) Symptoms and Quality of Life Measures with Splenomegaly Reduction in COMFORT-I: A Randomized, Double-Blind, Phase III Trial of the JAK1 and JAK2 Inhibitor Ruxolitinib Versus Placebo in Patients with MF, Blood. 118: 3842-3842. DOI: 10.1182/Blood.V118.21.3842.3842 |
0.367 |
|
| 2010 |
Mathew T, Shields A, Yanov S, Golubchikova V, Strelis A, Yanova G, Mishustin S, Fitzmaurice G, Connery H, Shin S, Greenfield SF. Performance of the alcohol use disorders identification test among tuberculosis patients in Russia. Substance Use & Misuse. 45: 598-612. PMID 20141466 DOI: 10.3109/10826080903464194 |
0.386 |
|
| 2010 |
Greenfield SF, Shields A, Connery HS, Livchits V, Yanov SA, Lastimoso CS, Strelis AK, Mishustin SP, Fitzmaurice G, Mathew TA, Shin S. Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation. Alcoholism, Clinical and Experimental Research. 34: 317-30. PMID 19930235 DOI: 10.1111/J.1530-0277.2009.01094.X |
0.316 |
|
| 2009 |
Mathew TA, Shields AL, Imasheva A, Shin SS, Mishustin SP, Peremitin GG, Strelis AK, Yanova GV, Greenfield SF, Furin JJ. Knowledge, attitudes, and practices of physicians in Tomsk Oblast tuberculosis services regarding alcohol use among tuberculosis patients in Tomsk, Russia. Culture, Medicine and Psychiatry. 33: 523-37. PMID 19768525 DOI: 10.1007/S11013-009-9148-0 |
0.319 |
|
| 2009 |
Miller CS, Woodson J, Howell RT, Shields AL. Assessing the reliability of scores produced by the substance abuse subtle screening inventory. Substance Use & Misuse. 44: 1090-100. PMID 19544146 DOI: 10.1080/10826080802486772 |
0.384 |
|
| 2009 |
Mathew TA, Yanov SA, Mazitov R, Mishustin SP, Strelis AK, Yanova GV, Golubchikova VT, Taran DV, Golubkov A, Shields AL, Greenfield SF, Shin SS. Integration of alcohol use disorders identification and management in the tuberculosis programme in Tomsk Oblast, Russia. European Journal of Public Health. 19: 16-8. PMID 19112073 DOI: 10.1093/Eurpub/Ckn093 |
0.36 |
|
| 2008 |
Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 11: 322-33. PMID 18380645 DOI: 10.1111/J.1524-4733.2007.00231.X |
0.327 |
|
| 2008 |
Howell RT, Shields AL. The file drawer problem in reliability generalization: A strategy to compute a fail-safe N with reliability coefficients Educational and Psychological Measurement. 68: 120-128. DOI: 10.1177/0013164407301528 |
0.334 |
|
| 2008 |
Shields AL, Campfield DC, Miller CS, Howell RT, Wallace K, Weiss RD. Score reliability of adolescent alcohol screening measures: A meta-analytic inquiry Journal of Child and Adolescent Substance Abuse. 17: 75-97. DOI: 10.1080/15470650802292855 |
0.406 |
|
| 2007 |
Shields AL, Howell RT, Potter JS, Weiss RD. The Michigan Alcoholism Screening Test and its shortened form: a meta-analytic inquiry into score reliability. Substance Use & Misuse. 42: 1783-800. PMID 17934995 DOI: 10.1080/10826080701212295 |
0.41 |
|
| 2007 |
Miller CS, Shields AL, Campfield D, Wallace KA, Weiss RD. Substance use scales of the Minnesota multiphasic personality inventory: An exploration of score reliability via meta-analysis Educational and Psychological Measurement. 67: 1052-1065. DOI: 10.1177/0013164406299130 |
0.435 |
|
| 2005 |
Shields AL, Hufford MR. Assessing motivation to change among problem drinkers with and without co-occurring major depression. Journal of Psychoactive Drugs. 37: 401-8. PMID 16480167 DOI: 10.1080/02791072.2005.10399813 |
0.327 |
|
| 2005 |
Ryngala DJ, Shields AL, Caruso JC. Reliability generalization of the revised children's manifest anxiety scale Educational and Psychological Measurement. 65: 259-271. DOI: 10.1177/0013164404272495 |
0.671 |
|
| 2004 |
Shields AL, Guttmannova K, Caruso JC. An examination of the factor structure of the Alcohol Use Disorders Identification Test in two high-risk samples. Substance Use & Misuse. 39: 1161-82. PMID 15387208 DOI: 10.1081/Ja-120038034 |
0.67 |
|
| 2004 |
Shields AL, Caruso JC. A Reliability Induction and Reliability Generalization Study of the Cage Questionnaire Educational and Psychological Measurement. 64: 254-270. DOI: 10.1177/0013164403261814 |
0.677 |
|
| 2003 |
Hufford MR, Witkiewitz K, Shields AL, Kodya S, Caruso JC. Relapse as a nonlinear dynamic system: application to patients with alcohol use disorders. Journal of Abnormal Psychology. 112: 219-27. PMID 12784831 DOI: 10.1037/0021-843X.112.2.219 |
0.644 |
|
| 2003 |
Shields AL, Caruso JC. Reliability generalization of the alcohol use disorders identification test Educational and Psychological Measurement. 63: 404-413. DOI: 10.1177/0013164403063003004 |
0.689 |
|
| 2002 |
Hufford MR, Shields AL, Shiffman S, Paty J, Balabanis M. Reactivity to ecological momentary assessment: an example using undergraduate problem drinkers. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 16: 205-11. PMID 12236455 DOI: 10.1037/0893-164X.16.3.205 |
0.32 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Mazar I, Lamoureux R, Ojo O, Kevane G, Banderas B, Stokes J, Shields A. Telephone Versus face-to-face Interviews for Patient-Reported Outcome Instrument Development. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A718. PMID 26534023 DOI: 10.1016/J.Jval.2015.09.2718 |
0.297 |
|
| 2020 |
Politei JM, Shields AL, Lamoureux RE, Taylor F, Zar-Kessler C, Barth JA, Skuban N. Fabry patient-reported outcome-gastrointestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument Molecular Genetics and Metabolism. 129. DOI: 10.1016/J.Ymgme.2019.11.340 |
0.296 |
|
| 2018 |
Yu-Isenberg K, Gray GD, Foley C, Stokes JT, Shields A, Dickie G, Lamoureux R, Jackson CV, Padilla B, Polonsky W. Patient Perspectives on the Burden of Type 2 Diabetes Mellitus Treatment Diabetes. 67. DOI: 10.2337/Db18-726-P |
0.294 |
|
| 2014 |
Trask PC, Taylor F, Shields A, Mehta J, Foley C, Olude O, Lamoureux R, Iovin R, Hsu K. Qualitative Assessment of Multiple Myeloma Symptoms and Health-Related Quality of Life in Relapsed/Refractory Patients and Comparison to the Eortc Qlq-C30 and My-20, Fact-Mm, and Mdasi-Mm Value in Health. 17. DOI: 10.1016/J.Jval.2014.03.541 |
0.294 |
|
| 2015 |
Lamoureux RE, Shields A, Stokes J, Yaworsky A, Galipeau N. How many subjects are enough for symptom-focused concept elicitation studies? A retrospective analysis of saturation across twenty-six studies Value in Health. 18. DOI: 10.1016/J.Jval.2015.03.198 |
0.283 |
|
| 2016 |
Ojo O, Shields A, Morrissey L, Love E, Ollis S, Halling K, Rudell K. Developing A Small Cell Lung Cancer Conceptual Model to Inform Treatment Outcome and Assessment Strategy Decisions in Clinical Research Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.2288 |
0.277 |
|
| 2016 |
Shields A, Stokes J, Foley C, Banderas B, Sundaram M. Simultaneous Development Of Pro Questionnaires For Use In Clinical Trials And ‘Real-World’ Situations Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.1758 |
0.276 |
|
| 2016 |
Jacobson TA, Edelman SV, Galipeau N, Shields AL, Mallya UG, Koren A, Davidson MH. Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©. The Patient. PMID 27981439 DOI: 10.1007/S40271-016-0211-Y |
0.274 |
|
| 2021 |
Taylor F, Akin C, Lamoureux RE, Padilla B, Green T, Boral AL, Mazar I, Mar B, Shields AL, Siebenhaar F. Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF. Orphanet Journal of Rare Diseases. 16: 414. PMID 34627355 DOI: 10.1186/s13023-021-02035-5 |
0.274 |
|
| 2016 |
Eek D, Krohe M, Mazar I, Horsfield A, Pompilus F, Friebe R, Shields AL. Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature. Patient Preference and Adherence. 10: 1609-21. PMID 27601886 DOI: 10.2147/Ppa.S106629 |
0.272 |
|
| 2020 |
Turner-Bowker DM, Yaworsky A, Palladino A, Lamoureux RE, Kelly M, Love E, Pleil AM, Shields A, Loftus J. Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults. The Patient. PMID 31956960 DOI: 10.1007/S40271-019-00405-7 |
0.268 |
|
| 2013 |
Shin S, Livchits V, Connery HS, Shields A, Yanov S, Yanova G, Fitzmaurice GM, Nelson AK, Greenfield SF. Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia. Addiction (Abingdon, England). 108: 1387-96. PMID 23490304 DOI: 10.1111/Add.12148 |
0.246 |
|
| 2018 |
Turner-Bowker D, Yaworsky A, Palladino A, Pleil A, Shields A, Kelly M, Lamoureux R, Love E, Morrissey L, Loftus J. Psychometric Evaluation of Questionnaires Assessing Injection Regimen Burden in Growth Hormone Deficient (GHD) Adults and Children Treated with Growth Hormone Value in Health. 21. DOI: 10.1016/J.Jval.2018.04.1522 |
0.246 |
|
| 2018 |
Kimball AB, Sundaram M, Shields AL, Hudgens S, Okun M, Foley C, Ganguli A. Adalimumab Alleviates Skin Pain in Patients with Moderate to Severe Hidradenitis Suppurativa: Secondary Efficacy Results from the PIONEER I and PIONEER II Randomized Controlled Trials. Journal of the American Academy of Dermatology. PMID 29787843 DOI: 10.1016/J.Jaad.2018.05.015 |
0.244 |
|
| 2021 |
Gwaltney C, Stokes J, Aiudi A, Mazar I, Ollis S, Love E, Shields A. Development and content validity of the Barth Syndrome Symptom Assessment (BTHS-SA) for adolescents and adults. Orphanet Journal of Rare Diseases. 16: 264. PMID 34108006 DOI: 10.1186/s13023-021-01897-z |
0.238 |
|
| 2022 |
Gwaltney C, Stokes J, Aiudi A, Mazar I, Ollis S, Love E, Karaa A, Houts CR, Wirth RJ, Shields AL. Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease. Journal of Patient-Reported Outcomes. 6: 129. PMID 36562873 DOI: 10.1186/s41687-022-00534-y |
0.238 |
|
| 2021 |
Taylor F, Li X, Yip C, Padilla B, Mar B, Green T, Oren R, Boral AL, Lin HM, Shields AL, Gotlib J. Psychometric evaluation of the Advanced Systemic Mastocytosis Symptom Assessment Form (AdvSM-SAF). Leukemia Research. 108: 106606. PMID 34004551 DOI: 10.1016/j.leukres.2021.106606 |
0.238 |
|
| 2021 |
Padilla B, Shields AL, Taylor F, Li X, Mcdonald J, Green T, Boral AL, Lin HM, Akin C, Siebenhaar F, Mar B. Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study. Orphanet Journal of Rare Diseases. 16: 434. PMID 34663404 DOI: 10.1186/s13023-021-02037-3 |
0.238 |
|
| 2023 |
Shields AL, Taylor F, Lamoureux RE, Padilla B, Severson K, Green T, Boral AL, Akin C, Siebenhaar F, Mar B. Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) and determination of a threshold score for moderate symptoms. Orphanet Journal of Rare Diseases. 18: 69. PMID 36964624 DOI: 10.1186/s13023-023-02661-1 |
0.234 |
|
| 2019 |
Mazar I, Stokes J, Ollis S, Love E, Espensen A, Barth PG, Powers JH, Shields AL. Understanding the life experience of Barth syndrome from the perspective of adults: a qualitative one-on-one interview study. Orphanet Journal of Rare Diseases. 14: 243. PMID 31699126 DOI: 10.1186/S13023-019-1200-8 |
0.234 |
|
| 2013 |
Stokes J, Yaworsky A, Galipeau N, Pompilus F, Foley C, Lamoureux R, Iovin R, Shields A. Evaluating and improving methods for cognitive debriefing pro questionnaires Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.263 |
0.234 |
|
| 2023 |
Taher AT, Musallam KM, Viprakasit V, Kattamis A, Lord-Bessen J, Yucel A, Guo S, Pelligra C, Shields AL, Shetty JK, Miteva D, Bueno LM, Cappellini MD. Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia. Bmj Open. 13: e066683. PMID 36948565 DOI: 10.1136/bmjopen-2022-066683 |
0.229 |
|
| 2012 |
Hillhouse JJ, Baker MK, Turrisi R, Shields A, Stapleton J, Jain S, Longacre I. Evaluating a measure of tanning abuse and dependence Archives of Dermatology. 148: 815-819. PMID 22801615 DOI: 10.1001/Archdermatol.2011.2929 |
0.218 |
|
| 2023 |
Peyrin-Biroulet L, Arenson E, Rubin DT, Siegel CA, Lee S, Laroux FS, Zhou W, Finney-Hayward T, Sanchez Gonzalez Y, Shields AL. A comparative evaluation of the measurement properties of three histological indices of mucosal healing in ulcerative colitis: Geboes Score, Robarts Histopathology Index, and Nancy Index. Journal of Crohn's & Colitis. PMID 37225135 DOI: 10.1093/ecco-jcc/jjad087 |
0.217 |
|
| 2013 |
Pleil A, Bushmakin AG, Shields A, Jensen J, Cappelleri JC. Determining The Magnitude Of A Detectable And A Relevant Treatment Benefit In Aesthetic Medicine Using A Photoguide And The Internet Value in Health. 16. DOI: 10.1016/J.Jval.2013.08.1781 |
0.214 |
|
| 2018 |
Shields A, Hudgens S, Spalding J, Kitt T, Ojo O, Kristy R, Mathias A, Morrissey L, Litcher-Kelly L, Houle C. Patient and Clinician Satisfaction with Pharmacological Stress Agents (PSAS) Used in Single Photon Emission Computerized Tomography Myocardial Perfusion Imaging (SPECT-MPI) Value in Health. 21. DOI: 10.1016/J.Jval.2018.04.1198 |
0.209 |
|
| 2020 |
Gwaltney C, Stokes J, Aiudi A, Mazar I, Ollis S, Love E, Espensen A, Shields AL. Development of a Patient-Reported Outcome Questionnaire to Evaluate Primary Mitochondrial Myopathy Symptoms: The Primary Mitochondrial Myopathy Symptom Assessment. Journal of Clinical Neuromuscular Disease. 22: 65-76. PMID 33214391 DOI: 10.1097/CND.0000000000000303 |
0.206 |
|
| 2020 |
Jairath V, Lee WJ, Zhou W, Heap G, Butler J, Shields AL, Ollis S, Harpaz N. P146 Comparison of three histologic indices in ulcerative colitis: Evaluation from the Phase 2 study of upadacitinib (U-ACHIEVE) Journal of Crohn's and Colitis. 14: S210-S211. DOI: 10.1093/ecco-jcc/jjz203.275 |
0.204 |
|
| 2021 |
Shields AL, Lamoureux RE, Taylor F, Barth JA, Mulberg AE, Kessler V, Skuban N. FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 33914257 DOI: 10.1007/s11136-021-02847-9 |
0.202 |
|
| 2017 |
Loftus J, Lamoureux R, Yaworsky A, Shields A, Morrissey L, Kelly M, Love E, Pleil A, Hart G, Hershkovitz O, Turner-Bowker D. Caregiver Burden In Daily Human Growth Hormone Injections For Children Value in Health. 20. DOI: 10.1016/J.Jval.2017.08.2140 |
0.196 |
|
| 2018 |
Reaney M, Stassek L, Martin M, McCarrier K, Slagle A, Shields A, Gwaltney CJ. Creating a personalized evaluation framework for patient-reported outcomes: an illustration using the EQ-5D visual analogue scale. Expert Review of Pharmacoeconomics & Outcomes Research. 1-8. PMID 30185076 DOI: 10.1080/14737167.2019.1519398 |
0.181 |
|
| 2016 |
Shields AL, Hao Y, Krohe M, Yaworsky A, Mazar I, Foley C, Mehmed F, Globe D. Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early Challenges. American Health & Drug Benefits. 9: 188-97. PMID 27688832 |
0.174 |
|
| 2016 |
Krohe M, Hao Y, Lamoureux RE, Galipeau N, Globe D, Foley C, Mazar I, Solomon J, Shields AL. Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials. Breast Cancer : Basic and Clinical Research. 10: 93-102. PMID 27441001 DOI: 10.4137/BCBCR.S39385 |
0.155 |
|
| 2013 |
Zagadailov E, Fine M, Shields A. Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers. American Health & Drug Benefits. 6: 264-74. PMID 24991362 |
0.137 |
|
| 2016 |
Sen R, Shields AL, Atsuda K. Patient Preference for Once-Weekly Dosing in Type 2 Diabetes Mellitus in Japan. Journal of Health Economics and Outcomes Research. 4: 55-66. PMID 37663012 DOI: 10.36469/9826 |
0.136 |
|
| 2016 |
Sen R, Shields AL, Atsuda K. Patient Preference for Once-Weekly Dosing in Type 2 Diabetes Mellitus in Japan. Journal of Health Economics and Outcomes Research. 4: 55-66. PMID 37663012 DOI: 10.36469/9826 |
0.136 |
|
| 2021 |
Clark D, Cavanagh B, Shields AL, Karpecki P, Sheppard J, Brady TC. Clinically Relevant Activity of the Novel RASP Inhibitor Reproxalap in Allergic Conjunctivitis: The Phase 3 ALLEVIATE Trial. American Journal of Ophthalmology. PMID 33945820 DOI: 10.1016/j.ajo.2021.04.023 |
0.115 |
|
| 2002 |
Hufford MR, Shields AL, Shiffman S, Paty J, Balabanis M. Reactivity to ecological momentary assessment: An example using undergraduate problem drinkers. Psychology of Addictive Behaviors. 16: 205-211. DOI: 10.1037/0893-164X.16.3.205 |
0.114 |
|
| 2016 |
Hao Y, Krohe M, Mazar I, Galipeau N, Foley C, Globe D, Turner-Bowker DM, Shields AL. Patient-reported outcomes in advanced breast cancer: inside the label and approval documents Expert Review of Quality of Life in Cancer Care. 1: 197-205. DOI: 10.1080/23809000.2016.1174068 |
0.112 |
|
| 2004 |
Dozmorov I, Knowlton N, Tang Y, Shields A, Pathipvanich P, Jarvis JN, Centola M. Hypervariable genes--experimental error or hidden dynamics. Nucleic Acids Research. 32: e147. PMID 15514108 DOI: 10.1093/nar/gnh146 |
0.068 |
|
| 2018 |
Rydén A, Ollis S, Love E, Shields A, Jiang H, Dennis P. 80P Understanding the patient perspective of small cell lung cancer (SCLC) Journal of Thoracic Oncology. 13: S44. DOI: 10.1016/S1556-0864(18)30355-1 |
0.065 |
|
| 2013 |
Philp I, Brainin M, Walker MF, Ward AB, Gillard P, Shields AL, Norrving B. Development of a poststroke checklist to standardize follow-up care for stroke survivors. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 22: e173-80. PMID 23265778 DOI: 10.1016/j.jstrokecerebrovasdis.2012.10.016 |
0.063 |
|
| 2007 |
Hillhouse J, Turrisi R, Shields AL. Patterns of indoor tanning use: implications for clinical interventions. Archives of Dermatology. 143: 1530-5. PMID 18087003 DOI: 10.1001/Archderm.143.12.1530 |
0.058 |
|
| Hide low-probability matches. |